Orchid Pharma (NSE:ORCHPHARMA) Other Net Income (Loss) : ₹-91 Mil (TTM As of Dec. 2023)

View and export this data going back to 1997. Start your Free Trial

What is Orchid Pharma Other Net Income (Loss)?

Orchid Pharma's Other Net Income (Loss) for the three months ended in Dec. 2023 was ₹-8 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 was ₹-91 Mil.

Orchid Pharma's quarterly Other Net Income (Loss) increased from Jun. 2023 (₹-14 Mil) to Sep. 2023 (₹-2 Mil) but then declined from Sep. 2023 (₹-2 Mil) to Dec. 2023 (₹-8 Mil).

Orchid Pharma's annual Other Net Income (Loss) increased from Mar. 2021 (₹-213 Mil) to Mar. 2022 (₹549 Mil) but then declined from Mar. 2022 (₹549 Mil) to Mar. 2023 (₹-89 Mil).

Orchid Pharma Other Net Income (Loss) Historical Data

The historical data trend for Orchid Pharma's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orchid Pharma Other Net Income (Loss) Chart

Orchid Pharma Annual Data

Trend

Mar12

Mar13

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Other Net Income (Loss)

Get a 7-Day Free Trial

-613.78

-212.81

549.48

-89.29

Orchid Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Net Income (Loss)	Get a 7-Day Free Trial															8.58	-67.91	-13.70	-2.20	-7.61

Orchid Pharma Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-91 Mil.

Orchid Pharma Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Orchid Pharma's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Orchid Pharma (NSE:ORCHPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orchid Pharma Ltd (NSE:ORCHPHARMA) » Definitions » Other Net Income (Loss)

Traded in Other Exchanges

524372:India

Address

313, Valluvarkottam High Road, Orchid Towers, Nungambakkum, Chennai, TN, IND, 600 034

Website

http://www.orchidpharma.com

Orchid Pharma Ltd is involved in the development, manufacturing, and marketing of diverse bulk actives, formulations, and nutraceuticals. The company operates in one business segment which is Pharmaceutical Products. The company produces various products for cardiovascular, anti-diabetic, neuropsychiatry, veterinary, non-antibiotics, and cephalosporins. The products are grouped under formulations and active pharmaceutical ingredients. The company operates its business throughout the Indian region.

Orchid Pharma (NSE:ORCHPHARMA) Headlines

No Headlines